EVerGel

N/A

Report date: 2025/06/11 11:02:21

Base Information

Drug NameEVerGel
Drug Alias NameEVerGel (Erganeo)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapyBiologics > Exosomes
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsGastrointestinal fistulaPerianal fistulaFibrosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEverzom
China Registration ClassN/A

Develop Information

Active CompaniesErganeo Sas
Inactive CompaniesEverzom
Active IndicationsGastrointestinal fistulaPerianal fistulaFibrosis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A